January 9, 2025
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 9:
Gain Therapeutics, Inc. GANX: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Gain Therapeutics, Inc. price-consensus-chart | Gain Therapeutics, Inc. Quote
Gain Therapeutics' shares gained 23.9% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of B.
Gain Therapeutics, Inc. price | Gain Therapeutics, Inc. Quote
First Hawaiian, Inc. FHB: This bank holding company for First Hawaiian Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
First Hawaiian, Inc. price-consensus-chart | First Hawaiian, Inc. Quote
First Hawaiian's shares gained 10.5% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of A.
First Hawaiian, Inc. price | First Hawaiian, Inc. Quote
The Travelers Companies, Inc. TRV: This insurance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.
The Travelers Companies, Inc. price-consensus-chart | The Travelers Companies, Inc. Quote
The Travelers Companies' shares gained 4.6% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of B.
The Travelers Companies, Inc. price | The Travelers Companies, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here .
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Travelers Companies, Inc. (TRV) : Free Stock Analysis Report
First Hawaiian, Inc. (FHB) : Free Stock Analysis Report
Gain Therapeutics, Inc. (GANX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research